Heart, Lung and Circulation
Volume 21, Issue 1 , Pages 1-11 , January 2012

Coronary Artery Bypass Surgery Provides Long-Term Results Superior to Percutaneous Coronary Intervention

  • Franklin L. Rosenfeldt, FRACS

      Affiliations

    • The Department of Surgery, The University of Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: Cardiac Surgical Research Unit, The Alfred Hospital, PO Box 315, Prahran Vic 3181, Australia.
    • ,
  • Mark D. Wilson, BSc

      Affiliations

    • Cardiac Surgical Research Unit, The Alfred Hospital and Monash University, Melbourne, Australia
    • ,
  • Brian F. Buxton, FRACS

      Affiliations

    • Cardiac Surgical Research Unit, The Alfred Hospital and Monash University, Melbourne, Australia
    • ,
  • Silvana F. Marasco, FRACS

      Affiliations

    • The Department of Surgery, The University of Melbourne, Australia

Received 24 February 2011 ,Revised 5 August 2011 ,Accepted 15 August 2011.

References 

  1. Fox KA. COURAGE to change practice? Revascularisation in patients with stable coronary artery disease. Heart. 2009;95(9):689
  2. Alserius T, Hammar N, Nordqvist T, Ivert T. Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus. J Thorac Cardiovasc Surg. 2009;138(5):1115
  3. Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients, 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55(5):432
  4. Brar SS, Syros G, Dangas G. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications. Angiology. 2008;59(2 Suppl.):83S
  5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315
  6. Tung R, Kaul S, Diamond GA, Shah PK. Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Ann Intern Med. 2006;144(12):913
  7. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115(9):1082
  8. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13
  9. Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S, Antman EM. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol. 2004;93(7):830
  10. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005;293(23):2908
  11. George BS, Voorhees WD, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol. 1993;22(1):135
  12. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999;341(26):1949
  13. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006;151(6):1260
  14. Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2411
  15. Windecker S, Meier B. Late coronary stent thrombosis. Circulation. 2007;116(17):1952
  16. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005;45(12):2088
  17. Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, et al. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry). Am J Cardiol. 2008;101(12):1716
  18. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27(22):2667
  19. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation. 2005;111(8):1040
  20. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297(2):159
  21. Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006. Circulation. 2007;115(17):2352
  22. Chhatriwalla AK, Bhatt DL. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year? Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely. Circ Cardiovasc Interv. 2008;1(3):217
  23. Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation. 2007;115(11):1433
  24. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007;49(6):734
  25. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, et al. Combining warfarin and antiplatelet therapy after coronary stenting in the global registry of acute coronary events: is it safe and effective to use just one antiplatelet agent?. Eur Heart J. 2007;28(14):1717
  26. Bell B, Layland J, Poon K, Spaulding C, Walters D. Focused clinical review: periprocedural management of antiplatelet therapy in patients with coronary stents. Heart Lung Circ. 2011;20(7):438
  27. Taggart DP. Thomas B. Ferguson Lecture. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg. 2006;82(6):1966
  28. Cohn WE. Surgical coronary revascularization remains relevant in the era of stents. Curr Opin Cardiol. 2004;19(6):589
  29. Schomig A, Mehilli J, de Waha A, Seyfarth M, Pache J, Kastrati A. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol. 2008;52(11):894
  30. van Domburg RT, Takkenberg JJ, Noordzij LJ, Saia F, van Herwerden LA, Serruys PW, et al. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study. Ann Thorac Surg. 2005;79(5):1563
  31. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41(8):1293
  32. Yap CH, Reid C, Yii M, Rowland MA, Mohajeri M, Skillington PD, et al. Validation of the EuroSCORE model in Australia. Eur J Cardiothorac Surg. 2006;29(4):441
  33. Cheng DC, Bainbridge D, Martin JE, Novick RJ. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology. 2005;102(1):188
  34. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation. 2001;104(5):533
  35. Investigators SoS. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360(9338):965
  36. Raja SG. Drug-eluting stents and the future of coronary artery bypass surgery: facts and fiction. Ann Thorac Surg. 2006;81(3):1162
  37. Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the acute catheterization and urgent intervention triage strategy trial. Circulation. 2009;119(5):687
  38. Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA. 2008;299(24):2868
  39. Gioia G, Matthai W, Gillin K, Dralle J, Benassi A, Gioia MF, et al. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheter Cardiovasc Interv. 2007;70(1):26
  40. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Stahle E, et al. Comparison of coronary by pass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3 year follow-up of the SYNTAX trial. Eur Heart J 2011, Jun 22, Epub ahead of print.
  41. The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49(15):1600
  42. Krone RJ, Rao SV, Dai D, Anderson HV, Peterson ED, Brown MA, et al. Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S., (a report from the American College of Cardiology/National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2010;3(9):902
  43. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344(8922):563
  44. Smith CR. Surgery, not percutaneous revascularization, is the preferred strategy for patients with significant left main coronary stenosis. Circulation. 2009;119(7):1013
  45. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67(4):1045
  46. Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg. 1998;66(5):1632
  47. Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005;130(2):512
  48. Herzog WR, Farb A. Severe coronary artery disease: is there a place for percutaneous coronary intervention?. Pol Arch Med Wewn. 2009;119(6):397
  49. Park SJ, Park DW. Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines?. Circ Cardiovasc Interv. 2009;2(1):59
  50. de Lezo JS, Medina A, Pan M, Delgado A, Segura J, Pavlovic D, et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary, disease. Am Heart J. 2004;148(3):481
  51. Task Force on Myocardial Revascularization of the European Society of Cardiology. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010;38:S1
  52. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg. 2004;77(1):93
  53. Tatoulis J, Buxton BF, Fuller JA, Royse AG. Total arterial coronary revascularization: techniques and results in 3,220 patients. Ann Thorac Surg. 1999;68(6):2093
  54. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006;114(18):1955
  55. Al Suwaidi J, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol. 2001;87(10):1139
  56. Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy SJ, et al. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart Lung Circ. 2009;18(3):184
  57. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States. JAMA. 2001–2008;305(17):1769
  58. King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory angioplasty versus surgery trial (EAST). J Am Coll Cardiol. 2000;35(5):1116
  59. Malenka DJ, Leavitt BJ, Hearne MJ, Robb JF, Baribeau YR, Ryan TJ, et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation. 2005;112(9 Suppl.):I371
  60. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352(21):2174
  61. Massoudy P, Thielmann M, Lehmann N, Marr A, Kleikamp G, Maleszka A, et al. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. J Thorac Cardiovasc Surg. 2009;137(4):840
  62. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373(9670):1190
  63. Cohen DJ, Lavelle TA, Van Hout B, Li H, Lei Y, Robertus K, et al. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or 3-vessel coronary artery disease: one-year results from sthe SYNTAX trial. Catheter Cardiovasc Interv 2011, May 3, Epub ahead of print.

PII: S1443-9506(11)01085-7

doi: 10.1016/j.hlc.2011.08.008

Heart, Lung and Circulation
Volume 21, Issue 1 , Pages 1-11 , January 2012

Article Tools

* Image Usage & Resolution